IPO Year In Review: Record-Year Bodes Well For 2021, And For More SPACs

86 Drug Developers Raised $17bn, Generated 86% Average Return

 
• By Mandy Jackson
  
Pixelated acronym IPO made from cubes, mosaic pattern
Out of 86 companies that went public last year, 67 were trading above their IPO values as of 27 January • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business